Lhasa Limited shared knowledge shared progress
Publications
  • Highlighted Item:
  • Publisher:
    PubMed
  • Publication Date:
    Oct 2010
  • Reference:
    Current Drug Discovery Technologies, 2010, 7(3), pp170-187
  • DOI:
  • PMID:
    20843294
  • Publication Type:
    Paper
  • Related Products:
  • Scientific Area:
  • Endpoint:
  • Industry Type:
  • Related event:

The in silico prediction of human-specific metabolites from hepatotoxic drugs

Long A; Valerio LG;

Valerio LG and Long A from Center for Drug Evaluation and Research, U.S. Food and Drug Administration and Lhasa Limited, respectively, present the use of a commercial software program to perform predictions in silico on seventeen hepatotoxic drugs for determining human-specific drug metabolites which might lead to chronic toxicity and cause potentially serious implications for clinical drug-drug interactions. The authors suggest that the proposed computational tools help support not only the development of therapeutics but also the safety assessment in identifying drug metabolites early to protect patients prior to initiating clinical studies.

Visit site

© 2020 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.